Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.

Caudron A, Battistella M, Feugeas JP, Pages C, Basset-Seguin N, Mazouz Dorval S, Funck Brentano E, Sadoux A, Podgorniak MP, Menashi S, Janin A, Lebbé C, Mourah S.

Exp Dermatol. 2016 Aug;25(8):618-22. doi: 10.1111/exd.13022.

PMID:
27060463
2.

Claudin-16 Deficiency Impairs Tight Junction Function in Ameloblasts, Leading to Abnormal Enamel Formation.

Bardet C, Courson F, Wu Y, Khaddam M, Salmon B, Ribes S, Thumfart J, Yamaguti PM, Rochefort GY, Figueres ML, Breiderhoff T, Garcia-Castaño A, Vallée B, Le Denmat D, Baroukh B, Guilbert T, Schmitt A, Massé JM, Bazin D, Lorenz G, Morawietz M, Hou J, Carvalho-Lobato P, Manzanares MC, Fricain JC, Talmud D, Demontis R, Neves F, Zenaty D, Berdal A, Kiesow A, Petzold M, Menashi S, Linglart A, Acevedo AC, Vargas-Poussou R, Müller D, Houillier P, Chaussain C.

J Bone Miner Res. 2016 Mar;31(3):498-513. doi: 10.1002/jbmr.2726.

PMID:
26426912
3.

Deletion of extracellular matrix metalloproteinase inducer/CD147 induces altered cardiac extracellular matrix remodeling in aging mice.

Huet E, Gabison E, Vallee B, Mougenot N, Linguet G, Riou B, Jarosz C, Menashi S, Besse S.

J Physiol Pharmacol. 2015 Jun;66(3):355-66.

4.

EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF.

Khayati F, Pérez-Cano L, Maouche K, Sadoux A, Boutalbi Z, Podgorniak MP, Maskos U, Setterblad N, Janin A, Calvo F, Lebbé C, Menashi S, Fernandez-Recio J, Mourah S.

Oncotarget. 2015;6(12):9766-80.

5.

EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells.

Delyon J, Khayati F, Djaafri I, Podgorniak MP, Sadoux A, Setterblad N, Boutalbi Z, Maouche K, Maskos U, Menashi S, Lebbé C, Mourah S.

Exp Dermatol. 2015 Jun;24(6):443-8. doi: 10.1111/exd.12693.

PMID:
25807898
6.

Grape seed extracts inhibit dentin matrix degradation by MMP-3.

Khaddam M, Salmon B, Le Denmat D, Tjaderhane L, Menashi S, Chaussain C, Rochefort GY, Boukpessi T.

Front Physiol. 2014 Oct 31;5:425. doi: 10.3389/fphys.2014.00425.

7.

A novel tumor suppressor function of Kindlin-3 in solid cancer.

Djaafri I, Khayati F, Menashi S, Tost J, Podgorniak MP, Sadoux A, Daunay A, Teixeira L, Soulier J, Idbaih A, Setterblad N, Fauvel F, Calvo F, Janin A, Lebbé C, Mourah S.

Oncotarget. 2014 Oct 15;5(19):8970-85.

8.

EMMPRIN/CD147 deficiency disturbs ameloblast-odontoblast cross-talk and delays enamel mineralization.

Khaddam M, Huet E, Vallée B, Bensidhoum M, Le Denmat D, Filatova A, Jimenez-Rojo L, Ribes S, Lorenz G, Morawietz M, Rochefort GY, Kiesow A, Mitsiadis TA, Poliard A, Petzold M, Gabison EE, Menashi S, Chaussain C.

Bone. 2014 Sep;66:256-66. doi: 10.1016/j.bone.2014.06.019.

PMID:
24970041
9.

Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the conjunctival epithelium exposed to antiglaucoma treatments.

Labbé A, Gabison E, Brignole-Baudouin F, Riancho L, Menashi S, Baudouin C.

Curr Eye Res. 2015 Jan;40(1):40-7. doi: 10.3109/02713683.2014.915574.

PMID:
24832574
10.

EMMPRIN/CD147-encriched membrane vesicles released from malignant human testicular germ cells increase MMP production through tumor-stroma interaction.

Milia-Argeiti E, Mourah S, Vallée B, Huet E, Karamanos NK, Theocharis AD, Menashi S.

Biochim Biophys Acta. 2014 Aug;1840(8):2581-8. doi: 10.1016/j.bbagen.2014.02.026.

PMID:
24608032
11.

Dentin matrix degradation by host matrix metalloproteinases: inhibition and clinical perspectives toward regeneration.

Chaussain C, Boukpessi T, Khaddam M, Tjaderhane L, George A, Menashi S.

Front Physiol. 2013 Nov 1;4:308. doi: 10.3389/fphys.2013.00308. Review.

12.

Cell membrane vesicles as a tool for the study of direct epithelial-stromal interaction: lessons from CD147.

Gabison E, Khayati F, Mourah S, Menashi S.

Methods Mol Biol. 2013;1066:103-11. doi: 10.1007/978-1-62703-604-7_9.

PMID:
23955737
13.

Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation.

Attia M, Huet E, Gossard C, Menashi S, Tassoni MC, Martelly I.

Am J Sports Med. 2013 Apr;41(4):908-17. doi: 10.1177/0363546512473817.

PMID:
23404084
14.

Multivalent pseudopeptides targeting cell surface nucleoproteins inhibit cancer cell invasion through tissue inhibitor of metalloproteinases 3 (TIMP-3) release.

Destouches D, Huet E, Sader M, Frechault S, Carpentier G, Ayoul F, Briand JP, Menashi S, Courty J.

J Biol Chem. 2012 Dec 21;287(52):43685-93. doi: 10.1074/jbc.M112.380402.

15.

Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasis.

Diamantopoulou Z, Kitsou P, Menashi S, Courty J, Katsoris P.

J Biol Chem. 2012 Nov 23;287(48):40339-49. doi: 10.1074/jbc.M112.405852.

16.

Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours.

Milia-Argeiti E, Huet E, Labropoulou VT, Mourah S, Fenichel P, Karamanos NK, Menashi S, Theocharis AD.

Int J Androl. 2012 Dec;35(6):835-44. doi: 10.1111/j.1365-2605.2012.01289.x.

PMID:
22712465
17.

EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.

Lescaille G, Menashi S, Cavelier-Balloy B, Khayati F, Quemener C, Podgorniak MP, Naïmi B, Calvo F, Lebbe C, Mourah S.

BMC Cancer. 2012 Mar 23;12:115. doi: 10.1186/1471-2407-12-115.

18.

A reliable method for the selection of exploitable melanoma archival paraffin embedded tissues for transcript biomarker profiling.

Lebbe C, Guedj M, Basset-Seguin N, Podgorniak MP, Menashi S, Janin A, Mourah S.

PLoS One. 2012;7(1):e29143. doi: 10.1371/journal.pone.0029143.

19.

EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease.

Huet E, Vallée B, Delbé J, Mourah S, Prulière-Escabasse V, Tremouilleres M, Kadomatsu K, Doan S, Baudouin C, Menashi S, Gabison EE.

Am J Pathol. 2011 Sep;179(3):1278-86. doi: 10.1016/j.ajpath.2011.05.036. Erratum in: Am J Pathol. 2011 Nov;179(5):2674.

20.

EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.

Bougatef F, Menashi S, Khayati F, Naïmi B, Porcher R, Podgorniak MP, Millot G, Janin A, Calvo F, Lebbé C, Mourah S.

PLoS One. 2010 Aug 31;5(8):e12265. doi: 10.1371/journal.pone.0012265.

Items per page

Supplemental Content

Loading ...
Support Center